NTRK2 and neuroblastoma: The downregulation of PHLDA1 also led to a significant increase in the expression of tropomyosin receptor kinase B (TRKB) and aurora A kinase, which are markers of poor prognosis in neuroblastoma (Brodeur et al. 2009; Durbas et al. 2016).